1. Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients
    Soumik Das et al, 2023, Medical Oncology CrossRef
  2. mTOR inhibitors from a diagnostic perspective: radiolabeling of everolimus and its nanoformulation, in vitro incorporation assays against cervix and ovarian cancer cells
    Ahmet Bilgi et al, 2022, Journal of Radioanalytical and Nuclear Chemistry CrossRef
  3. Streptomyces sp metabolite(s) promotes Bax mediated intrinsic apoptosis and autophagy involving inhibition of mTOR pathway in cervical cancer cell lines
    Vipin Mohan Dan et al, 2018, Scientific Reports CrossRef
  4. The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review
    Tara M. Hosseini et al, 2024, Cancers CrossRef
  5. Impact of PI3K-AKT-mTOR Signaling Pathway Up-regulation on Prognosis of Penile Squamous-Cell Carcinoma: Results From a Tissue Microarray Study and Review of the Literature
    Mounsif Azizi et al, 2019, Clinical Genitourinary Cancer CrossRef
  6. UBE2C Drives Human Cervical Cancer Progression and Is Positively Modulated by mTOR
    An-Jen Chiang et al, 2020, Biomolecules CrossRef
  7. Discovery of 3-(benzofuran-2-ylmethyl)-1H-indole derivatives as potential autophagy inducers in cervical cancer cells
    Shaziyaparveen K. Siddiqui et al, 2020, Bioorganic & Medicinal Chemistry Letters CrossRef
  8. Abemaciclib sensitizes HPV‐negative cervical cancer to chemotherapy via specifically suppressing CDK4/6‐Rb‐E2F and mTOR pathways
    Yuan Liu et al, 2021, Fundamental & Clinical Pharmacology CrossRef
  9. The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries
    Goonaseelan Pillai et al, 2018, BMC Medical Education CrossRef
  10. Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV– Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets
    Erik A. Williams et al, 2020, JCO Precision Oncology CrossRef
  11. PIK3CA Mutations and Their Impact on Survival Outcomes of Patients with Cervical Cancer: A Systematic Review
    Vasilios Pergialiotis et al, 2020, Acta Cytologica CrossRef

  12. circRNA MYLK Accelerates Cervical Cancer via Up-Regulation of RHEB and Activation of mTOR Signaling


    Rui Chen et al, 2020, Cancer Management and Research CrossRef
  13. Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer
    Thomas Bartl et al, 2023, Journal of Personalized Medicine CrossRef
  14. Additive cytotoxic effects of radiation and mTOR inhibitors in a cervical cancer cell line
    Daniele Xavier Assad et al, 2018, Pathology - Research and Practice CrossRef
  15. Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent chemoradiotherapy
    Man Ao et al, 2023, Journal of Obstetrics and Gynaecology CrossRef
  16. Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma
    Zorica Milošević et al, 2018, Cellular Oncology CrossRef
  17. Long non-coding RNA XLOC_008466 acts as an oncogenic molecular in cervical cancer tumorigenesis
    Fang Guo et al, 2018, Biomedicine & Pharmacotherapy CrossRef